Skip to content
Screener

Johnson & Johnson JNJ Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.34B-12.2%
Tenet Healthcare logo
Tenet HealthcareTHC
$1.78B+8.7%
Pfizer logo
PfizerPFE
$14.2B+6.8%
Procter & Gamble logo
Procter & GamblePG
$4.91B-19.7%
Merck & Co. logo
Merck & Co.MRK
$7.57B+7.7%
Stryker logo
StrykerSYK
$2.66B+1.2%

Other financials

Income statement

See full
Revenue$25.3B+6.6%
Gross profit$17.3B+7.1%
Operating income$7.1B+7.4%
Net income$5.5B-0.1%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$20.4B+9.9%
Total debt$49.0B-3.4%
Total equity$85.0B+8.3%
Total assets$201.06B+4.0%

Cash flow

See full
Operating cash flow$8.6B+122%
CapEx$1.3B+26.7%
Free cash flow$7.3B+157%

Valuation

See full
Market cap$619.3B+50.7%
Enterprise value$647.91B+46.2%
P/E29.4×+11.3×
P/S6.3×+1.8×

Profitability

See full
Gross margin67.9%0.0pp
Operating margin26.5%+2.8pp
Net margin21.5%-3.5pp
FCF margin22.7%+2.2pp

Returns & leverage

See full
Return on equity25.7%-4.5pp
Debt / equity0.6×-0.1×
Current ratio1.1×+0.1×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Johnson & Johnson’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:04 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000200406-26-000153
Line itemJune 28, 2026December 28, 2025
Deferred taxes on income (Note 5)6,6086,791
Employee related obligations (Note 6)6,6576,957
Long-term taxes payable (Note 5)485486
Other liabilities10,1019,868
Total liabilities$116,090117,666
Commitments and Contingencies (Note 11)
Shareholders’ equity:
Common stock — par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)$3,1203,120

Item 1 — Financial statements

FAQ

What is Johnson & Johnson's other non-current liabilities?
Johnson & Johnson (JNJ) reported other non-current liabilities of $10.1B in Q2 2026.
How has Johnson & Johnson's other non-current liabilities changed year-over-year?
Johnson & Johnson's other non-current liabilities decreased by 1.6% year-over-year, from $10.26B to $10.1B.
What is the long-term trend for Johnson & Johnson's other non-current liabilities?
Over 5 years (2020 to 2025), Johnson & Johnson's other non-current liabilities has grown at a -3.7% compound annual growth rate (CAGR), from $11.94B to $9.87B.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Johnson & Johnson's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude